Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page: https://medlineplus.gov/genetics/gene/xpa/

XPA gene

XPA, DNA damage recognition and repair factor

Normal Function

The XPA gene provides instructions for making a protein that is involved in repairing damaged DNA. DNA can be damaged by ultraviolet (UV) rays from sunlight and by toxic chemicals, radiation, and unstable molecules called free radicals.

DNA damage occurs frequently, but normal cells are usually able to fix it before it can cause problems. One of the major mechanisms that cells use to fix DNA is known as nucleotide excision repair (NER). As part of this repair mechanism, the XPA protein helps verify DNA damage and stabilize the DNA as it is repaired. The XPA protein attaches (binds) to areas of damaged DNA, where it interacts with many other proteins as part of a large complex. Proteins in this complex unwind the section of DNA where the damage has occurred, snip out (excise) the abnormal section, and replace the damaged area with the correct DNA.

Health Conditions Related to Genetic Changes

Xeroderma pigmentosum

Many variants (also called mutations) in the XPA gene have been found to cause xeroderma pigmentosum. People with this condition have an extreme sensitivity to UV rays from sunlight. As a result, affected individuals have a high risk of sunlight-induced cancer and premature aging. 

XPA gene variants are responsible for a very severe form of xeroderma pigmentosum that is more common in the Japanese population than in other populations. Most Japanese people with xeroderma pigmentosum have the same XPA gene variant, which is written as IVS3AS, G>C. This variant prevents cells from producing any functional XPA protein. Other XPA gene variants, which have been reported in Japan and elsewhere, result in the production of a nonfunctional version of the XPA protein or greatly reduce the amount of this protein that is made in cells.

A partial or total loss of the XPA protein prevents cells from repairing DNA damage normally. As damage builds up in DNA, cells malfunction and eventually become cancerous or die. These problems with DNA repair cause people with xeroderma pigmentosum to be extremely sensitive to UV rays. When UV rays damage genes that control cell growth and division, cells can grow too fast and in an uncontrolled way. This uncontrolled cell growth can lead to cancer. In people with xeroderma pigmentosum, these cancers occur most frequently in areas of the body that are exposed to the sun, such as the skin and eyes.

When xeroderma pigmentosum is caused by XPA gene variants, it is often associated with progressive neurological abnormalities. These nervous system problems include hearing loss, poor coordination, difficulty walking, movement problems, loss of intellectual function, difficulty swallowing and talking, and seizures. The neurological abnormalities are thought to result from a buildup of DNA damage, although the brain is not exposed to UV rays. Researchers suspect that other factors damage DNA in nerve cells. It is unclear why some people with xeroderma pigmentosum develop neurological abnormalities and others do not.

More About This Health Condition

Other Names for This Gene

  • xeroderma pigmentosum, complementation group A
  • XP1
  • XPA_HUMAN
  • XPAC

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Gene and Variant Databases

References

  • Camenisch U, Nageli H. XPA gene, its product and biological roles. Adv Exp Med Biol. 2008;637:28-38. doi: 10.1007/978-0-387-09599-8_4. Citation on PubMed
  • Cleaver JE, States JC. The DNA damage-recognition problem in human and other eukaryotic cells: the XPA damage binding protein. Biochem J. 1997 Nov 15;328 ( Pt 1)(Pt 1):1-12. doi: 10.1042/bj3280001. Citation on PubMed or Free article on PubMed Central
  • Cleaver JE, Thompson LH, Richardson AS, States JC. A summary of mutations in the UV-sensitive disorders: xeroderma pigmentosum, Cockayne syndrome, and trichothiodystrophy. Hum Mutat. 1999;14(1):9-22. doi: 10.1002/(SICI)1098-1004(1999)14:13.0.CO;2-6. Citation on PubMed
  • Hirai Y, Kodama Y, Moriwaki S, Noda A, Cullings HM, Macphee DG, Kodama K, Mabuchi K, Kraemer KH, Land CE, Nakamura N. Heterozygous individuals bearing a founder mutation in the XPA DNA repair gene comprise nearly 1% of the Japanese population. Mutat Res. 2006 Oct 10;601(1-2):171-8. doi: 10.1016/j.mrfmmm.2006.06.010. Epub 2006 Aug 14. Citation on PubMed
  • Jones CJ, Wood RD. Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA. Biochemistry. 1993 Nov 16;32(45):12096-104. doi: 10.1021/bi00096a021. Citation on PubMed
  • Satokata I, Iwai K, Matsuda T, Okada Y, Tanaka K. Genomic characterization of the human DNA excision repair-controlling gene XPAC. Gene. 1993 Dec 22;136(1-2):345-8. doi: 10.1016/0378-1119(93)90493-m. Citation on PubMed

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.